English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | May 8, 2024

American Lung Association Recognized for Innovative Work to Help People with Advanced Lung Disease
+ Pharmaceuticals
Patient Daily | May 8, 2024

Connecticut suspends funds for Tobacco and Health Trust Fund: American Lung Association reacts
+ Pharmaceuticals
Patient Daily | May 8, 2024

McGovern Medical School professor shapes future doctors through mentoring
+ Community
Patient Daily News Service | May 7, 2024

National Breathe Free Sinus and Allergy raises $110,000 for dog rescue organization
+ Pharmaceuticals
Patient Daily | May 7, 2024

American Lung Association Marks 10 Years of Progress in Ending Lung Cancer
+ Pharmaceuticals
Patient Daily | May 7, 2024

UTHealth Houston nurses recognized in Houston Chronicle's 2024 Salute to Nurses
+ Pharmaceuticals
Patient Daily | May 6, 2024

Young stroke survivor's journey underscores power of resilience and research
+ Pharmaceuticals
Patient Daily | May 6, 2024

Iowa governor signs bill requiring insurance coverage for biomarker tests

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation